Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Olaparib Combined with Abiraterone versus Olaparib Monotherapy for Patients with Metastatic Castration-resistant Prostate Cancer Progressing after Abiraterone and Harboring DNA Damage Repair Deficiency: A Multicenter Real-world Study

作者:Jun Xie, Hanxu Guo, Baijun Dong, Wei Chen, Chengqi Jin, Qiufan Xu, Li Ding, Wujianhong Liu, Shengrong Dong, Tingting Zhao, Yang Yu, Changcheng Guo, Xudong Yao, Bo Peng, Bin Yang · 发表于:European Urology Oncology · 年份:2024 · DOI:10.1016/j.euo.2024.02.005 · 被引用次数:12 · 研究领域:Prostate Cancer Treatment and Research、PARP inhibition in cancer therapy、Prostate Cancer Diagnosis and Treatment